Most Read Articles
29 Mar 2020
Targeting a low-density lipoprotein cholesterol level <70 mg/dL following an ischaemic stroke of atherosclerotic origin helps to avoid one in four subsequent major vascular events without increasing the risk of intracranial haemorrhage over about 5 years of follow-up, according to data from the Treat Stroke to Target trial.
Pearl Toh, 12 Sep 2020
Early initiation of rhythm-control therapy led to a significantly reduced risk of major adverse cardiovascular (CV) outcomes compared with usual care (typically rate control) in patients with newly diagnosed atrial fibrillation (AF) at risk of stroke, reveals the EAST-AFNET 4* trial presented at ESC 2020.
Audrey Abella, 16 Sep 2020
The final results of EVAPORATE* reinforce the plaque-regressing potential of icosapent ethyl (IPE) in patients on statins for elevated triglycerides.
01 Feb 2020
High-intensity statin therapy appears to be seeing increased use in patients with acute coronary syndrome and leads to better lipid control, according to a recent Thailand study.

Reablation common after cavo tricuspid isthmus ablation

14 Jan 2020

Reablation for atrial flutter and ablation for atrial fibrillation (AF) remain relatively common after cavo tricuspid isthmus ablation (CTIA), a recent study has found.

The study included 2,409 patients (median age, 66 years; 81 percent male) undergoing their first CTIA procedure between 2010 and 2016. Incidences of repeat CTIA or ablation for AF were documented until 1 March 2018. Majority of the population (n=2,288; 95 percent) achieved acute procedural success; 13 participants (0.5 percent) experienced complications.

Over a mean follow-up duration of 4.0±1.7 years, 242 patients required repeat CTIA, yielding a rate of 10 percent. Slightly more patients required ablation for AF (13.5 percent; n=326). Thirty-eight (2 percent) underwent both procedures.

Cox regression analysis found that patients who had longer operation times for the first CTIA procedure (hazard ratio [HR], 1.003, 95 percent confidence interval [CI], 1.001–1.006; p=0.01) and having an unsuccessful initial operation (HR, 3.42, 95 percent CI, 2.10–5.55; p<0.0001) were significantly more likely to need repeat procedures. Older age was likewise significantly associated (75 vs <65 years: HR, 0.66, 95 percent CI, 0.44–0.97; p=0.04).

In comparison, the use of a contact force sensing catheter emerged as a significant risk factor for having to undergo ablation for AF (HR, 1.43, 95 percent CI, 1.13–1.81; p=0.003). Other pertinent factors were the presence of valvular heart disease (HR, 0.39, 95 percent CI, 0.21–0.72; p=0.002) and known AF prior to CTIA (HR, 1.71, 95 percent CI, 1.07–2.73; p=0.02).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
29 Mar 2020
Targeting a low-density lipoprotein cholesterol level <70 mg/dL following an ischaemic stroke of atherosclerotic origin helps to avoid one in four subsequent major vascular events without increasing the risk of intracranial haemorrhage over about 5 years of follow-up, according to data from the Treat Stroke to Target trial.
Pearl Toh, 12 Sep 2020
Early initiation of rhythm-control therapy led to a significantly reduced risk of major adverse cardiovascular (CV) outcomes compared with usual care (typically rate control) in patients with newly diagnosed atrial fibrillation (AF) at risk of stroke, reveals the EAST-AFNET 4* trial presented at ESC 2020.
Audrey Abella, 16 Sep 2020
The final results of EVAPORATE* reinforce the plaque-regressing potential of icosapent ethyl (IPE) in patients on statins for elevated triglycerides.
01 Feb 2020
High-intensity statin therapy appears to be seeing increased use in patients with acute coronary syndrome and leads to better lipid control, according to a recent Thailand study.